GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...
Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...
On October 3, Amy Kane, 35, who once weighed 300 pounds at her heaviest, garnered 1.7 million views (@amyinhalf) after ...